Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AlloRx Stem Cells
- Development stage
- Phase 2
- Lead developer
- Vitro Biopharma
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intraarticular
01
Overview
AlloRx Stem Cells is an allogeneic umbilical cord-derived mesenchymal stem cell (UC-MSC) product developed by Vitro Biopharma. Manufactured under cGMP conditions, these cells are designed to leverage the immunomodulatory, anti-inflammatory, and regenerative properties inherent to mesenchymal stem cells. The therapy is being investigated for a diverse range of indications, including COVID-19 (to address cytokine storms and lung injury), Pitt Hopkins Syndrome (a rare neurodevelopmental disorder), and various musculoskeletal conditions such as osteoarthritis, ACL/MCL tears, and herniated discs. Vitro Biopharma has established international partnerships for clinical trials and patient treatments in jurisdictions including the Bahamas and the Cayman Islands, while also pursuing regulatory pathways with the FDA in the United States.
- Brand names
- AlloRx Stem Cells
- Other names
- umbilical cord mesenchymal stem cellsUC-MSCs
Beyond the preview
Go deeper on AlloRx Stem Cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlloRx Stem Cells.